Research Focus

Former Employee. MEDICINE; Research Project Manager

Recent additions – View all

1. Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma

   Meeting Abstract

   Teo, M. Y.; McBride, S.; Gopalan, A.; Benoliel, H.; Eastham, J. A.; Goh, A.; Szmulewitz, R.; Morgans, A. K.; Bubley, G.; Gupta, S.; more...
   Annals of Oncology (2021)

   Fulltext@MSK | Save
2. Features consistent with a small-cell neuroendocrine like (SC/NE-L) transformation can be readily detected and quantified in circulating tumor cells (CTCs)

   Meeting Abstract

   Scher, H. I.; Jendrisak, A.; Gilbertson, C.; Gill, A.; Barnett, E.; Gopalan, A.; Keegan, N.; Zaidi, S.; Benoliel, H.; Emily, C.; more...
   Cancer Research (2021)

   Fulltext@MSK | Save
3. Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane

   Meeting Abstract

   Scher, H. I.; Jendrisak, A.; Gill, A.; Barnett, E.; Gopalan, A.; Zaidi, S.; Benoliel, H.; Carbone, E.; Byun, J.; Schonhoft, J.; more...
   Journal of Clinical Oncology (2020)

   Fulltext@MSK | Save